Cargando…
A narrative review of toxicity of chemoradiation and immunotherapy for unresectable, locally advanced non-small cell lung cancer
Despite declining smoking rates, lung cancer remains the second most common malignancy in the United States and the leading cause of cancer-related mortality. Non-small cell lung cancer (NSCLC) comprises roughly 85% of cases, and patients tend to present with advanced disease. Historically, concurre...
Autores principales: | Prasad, Rahul N., Williams, Terence M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653152/ https://www.ncbi.nlm.nih.gov/pubmed/33209624 http://dx.doi.org/10.21037/tlcr-20-638 |
Ejemplares similares
-
Results of a Single Institution Experience with Dose-Escalated Chemoradiation for Locally Advanced Unresectable Non-Small Cell Lung Cancer
por: Bernard, Mark E., et al.
Publicado: (2017) -
Immunotherapy progress and clinical strategy of unresectable locally advanced non-small cell lung cancer
por: Zhang, Xiaofei, et al.
Publicado: (2023) -
Radiotherapy for unresectable locally advanced non-small cell lung cancer: a narrative review of the current landscape and future prospects in the era of immunotherapy
por: Guo, Tiantian, et al.
Publicado: (2020) -
Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma
por: Ha, Hyerim, et al.
Publicado: (2021) -
A prospective study investigating the efficacy and toxicity of definitive ChemoRadiation and ImmunOtherapy (CRIO) in locally and/or regionally advanced unresectable cutaneous squamous cell carcinoma
por: Lin, Charles, et al.
Publicado: (2021)